{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:59:01Z","timestamp":1785517141196,"version":"3.56.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"HMU Health and Medical University Potsdam GmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    WHO grade 2 meningiomas exhibit highly heterogeneous clinical courses. While the Ki67 proliferation index is a standard biomarker, its prognostic utility remains limited by methodological inconsistency and potential time-dependent dynamics. We evaluated an automated, artifact-adjusted Ki67 assessment and its integration with molecular risk profiling. 98 WHO grade 2 meningiomas (WHO 2021) were analyzed using an automated QuPath-based pipeline with HistoART for artifact exclusion. Molecular risk was defined by methylation and copy number profiling to calculate the integrated molecular-morphologic risk score by Maas et al. We employed extended Cox models to account for proportional hazards violations. Automated Ki67 values were significantly lower than routine pathological estimates (median 2.91% vs. 10%;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001) and correlated modestly with integrated risk scores (\u03c1\u2009=\u20090.26,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.009). We identified a biphasic risk pattern: within the first 38 postoperative months, an automated Ki67\u2009&gt;\u20093.62% was a strong independent predictor for local recurrence (HR 5.06,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001) and progression-free survival (HR 4.15,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.002), remaining significant alongside subtotal resection and the integrated risk group. Beyond 38 months, prognostic impact attenuated. Ki67 and the integrated molecular risk score contributed independently in multivariable models, suggesting complementary biological dimensions. Automated, artifact-adjusted Ki67 quantification provides time-dependent, independent prognostic information in WHO grade 2 meningioma, complementary to molecular risk stratification. It may serve as a cost-effective surveillance marker\u2014both as an adjunct to molecular profiling and as a standalone tool where molecular testing is unavailable.\n                  <\/jats:p>","DOI":"10.1186\/s40478-026-02387-8","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T19:15:01Z","timestamp":1785179701000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Time-dependent prognostic value of automated Ki67 assessment and its integration with molecular risk profiling in WHO grade 2 meningioma"],"prefix":"10.1186","volume":"14","author":[{"given":"Luisa","family":"Vo\u00dfbeck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6177-1755","authenticated-orcid":false,"given":"Felix","family":"Ehret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eilis","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Radbruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth G.","family":"Hain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Onken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merten","family":"Bohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabiha","family":"Salman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonille","family":"Schweizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1945-497X","authenticated-orcid":false,"given":"David","family":"Capper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7208-8548","authenticated-orcid":false,"given":"Moritz","family":"Armbrust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7906-5629","authenticated-orcid":false,"given":"David","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"2387_CR1","doi-asserted-by":"publisher","unstructured":"Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, et al (2023) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016\u20132020. Neuro-Oncol 25:iv1\u201399. https:\/\/doi.org\/10.1093\/neuonc\/noad149","DOI":"10.1093\/neuonc\/noad149"},{"key":"2387_CR2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.neuchi.2017.03.004","volume":"63","author":"C Champeaux","year":"2017","unstructured":"Champeaux C, Houston D, Dunn L (2017) Atypical meningioma. A study on recurrence and disease-specific survival. Neurochirurgie (Paris) 63:273\u2013281. https:\/\/doi.org\/10.1016\/j.neuchi.2017.03.004","journal-title":"Neurochirurgie (Paris)"},{"key":"2387_CR3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ijrobp.2018.09.019","volume":"103","author":"OC Barrett","year":"2019","unstructured":"Barrett OC, Hackney JR, McDonald AM, Willey CD, Bredel M, Fiveash JB (2019) Pathologic predictors of local recurrence in atypical meningiomas following gross total resection. Int J Radiat Oncol Biol Phys 103:453\u2013459. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.09.019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2387_CR4","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1016\/j.wneu.2024.04.082","volume":"187","author":"M Nadeem","year":"2024","unstructured":"Nadeem M, Goyal-Honavar A, Sravya P, Beniwal M, Santosh V, Dwarakanath S (2024) Prognostic factors and outcomes in World Health Organization grade 1 and grade 2 intracranial meningiomas-5-year institutional experience. World Neurosurg 187:e331\u2013e339. https:\/\/doi.org\/10.1016\/j.wneu.2024.04.082","journal-title":"World Neurosurg"},{"key":"2387_CR5","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/neuonc\/noab150","volume":"23","author":"R Goldbrunner","year":"2021","unstructured":"Goldbrunner R, Stavrinou P, Jenkinson MD, Sahm F, Mawrin C, Weber DC et al (2021) EANO guideline on the diagnosis and management of meningiomas. Neuro Oncol 23:1821\u20131834. https:\/\/doi.org\/10.1093\/neuonc\/noab150","journal-title":"Neuro Oncol"},{"key":"2387_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/978-3-031-29750-2_2","volume-title":"Biol Clin Landsc Meningiomas","author":"CP Millward","year":"2023","unstructured":"Millward CP, Keshwara S, Islim AI, Zakaria R, Jenkinson MD (2023) Clinical presentation and prognosis. In: Zadeh G, Goldbrunner R, Krischek B, Nassiri F (eds) Biol Clin Landsc Meningiomas. Springer International Publishing, Cham, pp 5\u201320"},{"key":"2387_CR7","first-page":"283","volume-title":"Meningiomas","author":"F Sahm","year":"2021","unstructured":"Sahm F, Perry A, von Deimling A, Claus EB, Mawrin C, Brastianos PK et al (2021) Meningiomas, 5th ed. International Agency for Research on Cancer, Lyon, pp 283\u2013298","edition":"5th ed"},{"key":"2387_CR8","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1080\/0284186X.2022.2116994","volume":"61","author":"C Wujanto","year":"2022","unstructured":"Wujanto C, Chan TY, Soon YY, Vellayappan B (2022) Should adjuvant radiotherapy be used in atypical meningioma (WHO grade 2) following gross total resection? a systematic review and meta-analysis. Acta Oncol 61:1075\u20131083. https:\/\/doi.org\/10.1080\/0284186X.2022.2116994","journal-title":"Acta Oncol"},{"key":"2387_CR9","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ijrobp.2020.08.015","volume":"109","author":"G Lee","year":"2021","unstructured":"Lee G, Lamba N, Niemierko A, Kim DW, Chapman PH, Loeffler JS et al (2021) Adjuvant radiation therapy versus surveillance after surgical resection of atypical meningiomas. Int J Radiat Oncol Biol Phys 109:252\u2013266. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.08.015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2387_CR10","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469\u2013474. https:\/\/doi.org\/10.1038\/nature26000","journal-title":"Nature"},{"key":"2387_CR11","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","volume":"18","author":"F Sahm","year":"2017","unstructured":"Sahm F, Schrimpf D, Stichel D, Jones DTW, Hielscher T, Schefzyk S et al (2017) DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol 18:682\u2013694. https:\/\/doi.org\/10.1016\/S1470-2045(17)30155-9","journal-title":"Lancet Oncol"},{"key":"2387_CR12","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1200\/JCO.21.00784","volume":"39","author":"SLN Maas","year":"2021","unstructured":"Maas SLN, Stichel D, Hielscher T, Sievers P, Berghoff AS, Schrimpf D et al (2021) Integrated molecular-morphologic meningioma classification: a multicenter retrospective analysis, retrospectively and prospectively validated. J Clin Oncol 39:3839\u20133852. https:\/\/doi.org\/10.1200\/JCO.21.00784","journal-title":"J Clin Oncol"},{"key":"2387_CR13","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/neuonc\/noz061","volume":"21","author":"F Nassiri","year":"2019","unstructured":"Nassiri F, Mamatjan Y, Suppiah S, Badhiwala JH, Mansouri S, Karimi S et al (2019) DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management. Neuro-oncol 21:901\u2013910. https:\/\/doi.org\/10.1093\/neuonc\/noz061","journal-title":"Neuro-oncol"},{"key":"2387_CR14","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41588-022-01061-8","volume":"54","author":"A Choudhury","year":"2022","unstructured":"Choudhury A, Magill ST, Eaton CD, Prager BC, Chen WC, Cady MA et al (2022) Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. Nat Genet 54:649\u2013659. https:\/\/doi.org\/10.1038\/s41588-022-01061-8","journal-title":"Nat Genet"},{"key":"2387_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s40478-024-01739-6","volume":"12","author":"F Ehret","year":"2024","unstructured":"Ehret F, Perez E, Teichmann D, Meier S, Geiler C, Zeus C et al (2024) Clinical implications of DNA methylation-based integrated classification of histologically defined grade 2 meningiomas. Acta Neuropathol Commun 12:74. https:\/\/doi.org\/10.1186\/s40478-024-01739-6","journal-title":"Acta Neuropathol Commun"},{"key":"2387_CR16","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1093\/neuonc\/noae082","volume":"26","author":"JZ Wang","year":"2024","unstructured":"Wang JZ, Landry AP, Raleigh DR, Sahm F, Walsh KM, Goldbrunner R et al (2024) Meningioma: international consortium on meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients. Neuro-oncol 26:1742\u20131780. https:\/\/doi.org\/10.1093\/neuonc\/noae082","journal-title":"Neuro-oncol"},{"key":"2387_CR17","doi-asserted-by":"publisher","first-page":"e18644","DOI":"10.1097\/MD.0000000000018644","volume":"99","author":"N Liu","year":"2020","unstructured":"Liu N, Song S-Y, Jiang J-B, Wang T-J, Yan C-X (2020) The prognostic role of Ki-67\/MIB-1 in meningioma: a systematic review with meta-analysis. Med (Baltimore) 99:e18644. https:\/\/doi.org\/10.1097\/MD.0000000000018644","journal-title":"Med (Baltimore)"},{"key":"2387_CR18","doi-asserted-by":"publisher","first-page":"e0303337","DOI":"10.1371\/journal.pone.0303337","volume":"19","author":"TM Aung","year":"2024","unstructured":"Aung TM, Ngamjarus C, Proungvitaya T, Saengboonmee C, Proungvitaya S (2024) Biomarkers for prognosis of meningioma patients: a systematic review and meta-analysis. PLoS ONE 19:e0303337. https:\/\/doi.org\/10.1371\/journal.pone.0303337","journal-title":"PLoS ONE"},{"key":"2387_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/nlaf131","author":"A Broechner","year":"2025","unstructured":"Broechner A, Maier AD, Mirian C, Sahm F, Hamelmann S, Ratliff M et al (2025) Analysis of anatomical location, mitoses, and Ki-67 in 2608 meningiomas. J Neuropathol Exp Neurol. https:\/\/doi.org\/10.1093\/jnen\/nlaf131","journal-title":"J Neuropathol Exp Neurol"},{"key":"2387_CR20","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/neuros\/nyaa226","volume":"87","author":"C Mirian","year":"2020","unstructured":"Mirian C, Skyrman S, Bartek JJ, Jensen LR, Kihlstr\u00f6m L, F\u00f6rander P et al (2020) The Ki-67 proliferation index as a marker of time to recurrence in intracranial meningioma. Neurosurg 87:1289. https:\/\/doi.org\/10.1093\/neuros\/nyaa226","journal-title":"Neurosurg"},{"key":"2387_CR21","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/apm.12248","volume":"122","author":"T Backer-Gr\u00f8ndahl","year":"2014","unstructured":"Backer-Gr\u00f8ndahl T, Moen BH, Sundstr\u00f8m SH, Torp SH (2014) Histopathology and prognosis in human meningiomas. APMIS 122:856\u2013866. https:\/\/doi.org\/10.1111\/apm.12248","journal-title":"APMIS"},{"key":"2387_CR22","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/neuonc\/nov247","volume":"18","author":"CL Rogers","year":"2016","unstructured":"Rogers CL, Perry A, Pugh S, Vogelbaum MA, Brachman D, McMillan W et al (2016) Pathology concordance levels for meningioma classification and grading in NRG oncology RTOG trial 0539. Neuro-oncol 18:565\u2013574. https:\/\/doi.org\/10.1093\/neuonc\/nov247","journal-title":"Neuro-oncol"},{"key":"2387_CR23","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.prp.2010.09.002","volume":"206","author":"E Abry","year":"2010","unstructured":"Abry E, Thomassen I\u00d8, Salvesen \u00d8O, Torp SH (2010) The significance of Ki-67\/MIB-1 labeling index in human meningiomas: a literature study. Pathol Res Pract 206:810\u2013815. https:\/\/doi.org\/10.1016\/j.prp.2010.09.002","journal-title":"Pathol Res Pract"},{"key":"2387_CR24","doi-asserted-by":"publisher","unstructured":"Polley M-YC, Leung SCY, Gao D, Mastropasqua MG, Zabaglo LA, Bartlett JMS, et al (2015) An international study to increase concordance in Ki67 scoring. Mod Pathol. Nature Publishing Group 28:778\u201386. https:\/\/doi.org\/10.1038\/modpathol.2015.38","DOI":"10.1038\/modpathol.2015.38"},{"key":"2387_CR25","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, Dombrowski Y, McArt DG, Dunne PD et al (2017) QuPath: open source software for digital pathology image analysis. Sci Rep 7:16878. https:\/\/doi.org\/10.1038\/s41598-017-17204-5","journal-title":"Sci Rep"},{"key":"2387_CR26","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.3171\/2024.4.JNS232857","volume":"141","author":"V Thirunavu","year":"2024","unstructured":"Thirunavu V, Drumm M, McCord M, Steffens A, Youngblood MW, Nandoliya KR et al (2024) Optimizing the use of Ki-67 proliferative index as a prognostic biomarker in meningiomas using digital analysis. J Neurosurg 141:1644\u20131654. https:\/\/doi.org\/10.3171\/2024.4.JNS232857","journal-title":"J Neurosurg"},{"key":"2387_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11060-020-03688-1","volume":"152","author":"K Nowak-Choi","year":"2021","unstructured":"Nowak-Choi K, Palmer JD, Casey J, Chitale A, Kalchman I, Buss E et al (2021) Resected WHO grade I meningioma and predictors of local control. J Neurooncol 152:145\u2013151. https:\/\/doi.org\/10.1007\/s11060-020-03688-1","journal-title":"J Neurooncol"},{"key":"2387_CR28","doi-asserted-by":"publisher","first-page":"58821","DOI":"10.1109\/ACCESS.2022.3176091","volume":"10","author":"N Kanwal","year":"2022","unstructured":"Kanwal N, Perez-Bueno F, Schmidt A, Engan K, Molina R (2022) The devil is in the details: whole slide image acquisition and processing for artifacts detection, color variation, and data augmentation: a review. IEEE Access 10:58821\u201358844. https:\/\/doi.org\/10.1109\/ACCESS.2022.3176091","journal-title":"IEEE Access"},{"key":"2387_CR29","doi-asserted-by":"publisher","unstructured":"Kahaki S, Webber AR, Zamzmi G, Subbaswamy A, Deshpande R, Badano A (2025) HistoART: Histopathology artifact detection and reporting tool [Internet]. arXiv; https:\/\/doi.org\/10.48550\/arXiv.2507.00044 [cited 2 Dec 2025]","DOI":"10.48550\/arXiv.2507.00044"},{"key":"2387_CR30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1136\/jnnp.20.1.22","volume":"20","author":"D Simpson","year":"1957","unstructured":"Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2387_CR31","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1126\/science.1233009","volume":"339","author":"VE Clark","year":"2013","unstructured":"Clark VE, Erson-Omay EZ, Serin A, Yin J, Cotney J, Ozduman K et al (2013) Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Sci 339:1077\u20131080. https:\/\/doi.org\/10.1126\/science.1233009","journal-title":"Sci"},{"key":"2387_CR32","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3171\/2015.7.JNS15546","volume":"125","author":"A Mansouri","year":"2016","unstructured":"Mansouri A, Klironomos G, Taslimi S, Kilian A, Gentili F, Khan OH et al (2016) Surgically resected skull base meningiomas demonstrate a divergent postoperative recurrence pattern compared with non-skull base meningiomas. J Neurosurg 125:431\u2013440. https:\/\/doi.org\/10.3171\/2015.7.JNS15546","journal-title":"J Neurosurg"},{"key":"2387_CR33","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3171\/2019.8.JNS191266","volume":"133","author":"MW Youngblood","year":"2020","unstructured":"Youngblood MW, Duran D, Montejo JD, Li C, Omay SB, \u00d6zduman K et al (2020) Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas. J Neurosurg 133:1345\u20131354. https:\/\/doi.org\/10.3171\/2019.8.JNS191266","journal-title":"J Neurosurg"},{"key":"2387_CR34","doi-asserted-by":"publisher","unstructured":"Dosovitskiy A, Beyer L, Kolesnikov A, Weissenborn D, Zhai X, Unterthiner T, et al (2021) An image is worth 16x16 words: transformers for image recognition at scale [Internet]. arXiv; https:\/\/doi.org\/10.48550\/arXiv.2010.11929 [cited 2 Dec 2025]","DOI":"10.48550\/arXiv.2010.11929"},{"key":"2387_CR35","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/s41591-024-02857-3","volume":"30","author":"RJ Chen","year":"2024","unstructured":"Chen RJ, Ding T, Lu MY, Williamson DFK, Jaume G, Song AH et al (2024) Towards a general-purpose foundation model for computational pathology. Nat Med 30:850\u2013862. https:\/\/doi.org\/10.1038\/s41591-024-02857-3","journal-title":"Nat Med"},{"key":"2387_CR36","doi-asserted-by":"publisher","unstructured":"Daenekas B, P\u00e9rez E, Boniolo F, Stefan S, Benfatto S, Sill M et al (2024) Conumee 2.0: enhanced copy-number variation analysis from DNA methylation arrays for humans and mice. Bioinforma Oxf Engl 40(2):btae029 https:\/\/doi.org\/10.1093\/bioinformatics\/btae029","DOI":"10.1093\/bioinformatics\/btae029"},{"key":"2387_CR37","doi-asserted-by":"publisher","first-page":"e13132","DOI":"10.1111\/bpa.13132","volume":"33","author":"T Hielscher","year":"2022","unstructured":"Hielscher T, Sill M, Sievers P, Stichel D, Brandner S, Jones DTW et al (2022) Clinical implementation of integrated molecular\u2010morphologic risk prediction for meningioma. Brain Pathol 33:e13132. https:\/\/doi.org\/10.1111\/bpa.13132","journal-title":"Brain Pathol"},{"key":"2387_CR38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-1-4757-3294-8_3","volume-title":"Model surviv data extending cox model","author":"TM Therneau","year":"2000","unstructured":"Therneau TM, Grambsch PM (2000) The cox model. In: Therneau TM, Grambsch PM (eds) Model surviv data extending cox model. Springer New York, New York, NY, pp 39\u201377. https:\/\/doi.org\/10.1007\/978-1-4757-3294-8_3"},{"key":"2387_CR39","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/978-1-4612-1694-0_16","volume-title":"Sel pap Hirotugu Akaike","author":"H Akaike","year":"1998","unstructured":"Akaike H (1998) A new look at the statistical model identification. In: Parzen E, Tanabe K, Kitagawa G (eds) Sel pap Hirotugu Akaike. Springer, New York, NY, pp 215\u2013222. https:\/\/doi.org\/10.1007\/978-1-4612-1694-0_16"},{"key":"2387_CR40","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.0006-341x.2000.00337.x","volume":"56","author":"PJ Heagerty","year":"2000","unstructured":"Heagerty PJ, Lumley T, Pepe MS (2000) Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 56:337\u2013344. https:\/\/doi.org\/10.1111\/j.0006-341x.2000.00337.x","journal-title":"Biometrics"},{"key":"2387_CR41","doi-asserted-by":"publisher","unstructured":"Youden WJ (1950) Index for rating diagnostic tests. Cancer 3:32\u20135. https:\/\/doi.org\/10.1002\/1097-0142(1950)3:1%3C32::aid-cncr2820030106%3E3.0.co;2-3","DOI":"10.1002\/1097-0142(1950)3:1%3C32::aid-cncr2820030106%3E3.0.co;2-3"},{"key":"2387_CR42","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY (2016) A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 15:155\u2013163. https:\/\/doi.org\/10.1016\/j.jcm.2016.02.012","journal-title":"J Chiropr Med"},{"key":"2387_CR43","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3171\/2025.4.JNS25438","volume":"143","author":"X Guo","year":"2025","unstructured":"Guo X, Patel RV, Lederer JA, Meredith DM, Bi WL (2025) Ki-67 in meningioma: distribution and implications. J Neurosurg 143:1325\u20131335. https:\/\/doi.org\/10.3171\/2025.4.JNS25438","journal-title":"J Neurosurg"},{"key":"2387_CR44","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/jnen\/nlaf043","volume":"84","author":"U Ugwuowo","year":"2025","unstructured":"Ugwuowo U, Faust B, Tang H, DiStasio M (2025) Adequate capture of spatial heterogeneity of Ki-67 proliferative index in meningiomas requires multiple tissue sections. J Neuropathol Exp Neurol 84:1067\u20131070. https:\/\/doi.org\/10.1093\/jnen\/nlaf043","journal-title":"J Neuropathol Exp Neurol"},{"key":"2387_CR45","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/1066896919889148","volume":"28","author":"DT Pham","year":"2020","unstructured":"Pham DT, Skaland I, Winther TL, Salvesen \u00d8, Torp SH (2020) Correlation between digital and manual determinations of Ki-67\/MIB-1 proliferative indices in human meningiomas. Int J Surg Pathol 28:273\u2013279. https:\/\/doi.org\/10.1177\/1066896919889148","journal-title":"Int J Surg Pathol"},{"key":"2387_CR46","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jocn.2024.04.015","volume":"124","author":"M Mizrachi","year":"2024","unstructured":"Mizrachi M, Hartley B, Saleem S, Hintz E, Ziemba Y, Li J et al (2024) Ki-67 index as a predictive marker of meningioma recurrence following surgical resection. J Clin Neurosci 124:15\u201319. https:\/\/doi.org\/10.1016\/j.jocn.2024.04.015","journal-title":"J Clin Neurosci"},{"key":"2387_CR47","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s10143-024-02485-y","volume":"47","author":"PR Wagle","year":"2024","unstructured":"Wagle PR, Loeschner D, Rosahl S, Brodhun M, Gerlach R (2024) A comprehensive correlation of the KI-67 proliferation index to patient\u2019s, imaging and tumor features and its value in predicting long-term course of patients with newly diagnosed intracranial meningiomas. Neurosurg Rev 47:241. https:\/\/doi.org\/10.1007\/s10143-024-02485-y","journal-title":"Neurosurg Rev"},{"key":"2387_CR48","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3390\/cancers15020535","volume":"15","author":"G Gauchotte","year":"2023","unstructured":"Gauchotte G, B\u00e9del C, Lardenois E, Hergalant S, Cuglietta L, Pflaum R et al (2023) A high MCM6 proliferative index in atypical meningioma is associated with shorter progression free and overall survivals. Cancers (Basel) 15:535. https:\/\/doi.org\/10.3390\/cancers15020535","journal-title":"Cancers (Basel)"},{"key":"2387_CR49","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/PAI.0000000000000864","volume":"29","author":"EJ van den Berg","year":"2021","unstructured":"van den Berg EJ, Duarte R, Dickens C, Joffe M, Mohanlal R (2021) KI67 immunohistochemistry quantification in breast carcinoma: a comparison of visual estimation, counting and Immunoratio\u00a9. Appl Immunohistochem Mol Morphol 29:105\u2013111. https:\/\/doi.org\/10.1097\/PAI.0000000000000864","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"2387_CR50","doi-asserted-by":"publisher","first-page":"152441","DOI":"10.1016\/j.anndiagpath.2025.152441","volume":"75","author":"S Guresci","year":"2025","unstructured":"Guresci S, Aydogdu OB, Secen AE, Uzel B (2025) Assessing the predictive value of Ki-67 and progesterone receptor algorithms for recurrence and disease-free survival in meningiomas. Ann Diagn Pathol 75:152441. https:\/\/doi.org\/10.1016\/j.anndiagpath.2025.152441","journal-title":"Ann Diagn Pathol"},{"key":"2387_CR51","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/path.5921","volume":"257","author":"P Bankhead","year":"2022","unstructured":"Bankhead P (2022) Developing image analysis methods for digital pathology. J Pathol 257:391\u2013402. https:\/\/doi.org\/10.1002\/path.5921","journal-title":"J Pathol"},{"key":"2387_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-024-07352-4","volume":"207","author":"E Rewcastle","year":"2024","unstructured":"Rewcastle E, Skaland I, Gudlaugsson E, Fykse SK, Baak JPA, Janssen EAM (2024) The Ki67 dilemma: investigating prognostic cut-offs and reproducibility for automated Ki67 scoring in breast cancer. Breast Cancer Res Treat 207:1\u201312. https:\/\/doi.org\/10.1007\/s10549-024-07352-4","journal-title":"Breast Cancer Res Treat"},{"key":"2387_CR53","doi-asserted-by":"publisher","first-page":"498746","DOI":"10.1155\/2015\/498746","volume":"2015","author":"Z Swiderska","year":"2015","unstructured":"Swiderska Z, Korzynska A, Markiewicz T, Lorent M, Zak J, Wesolowska A et al (2015) Comparison of the manual, semiautomatic, and automatic selection and leveling of hot spots in whole slide images for Ki-67 quantification in meningiomas. Anal Cell Pathol Amst 2015:498746. https:\/\/doi.org\/10.1155\/2015\/498746","journal-title":"Anal Cell Pathol Amst"},{"key":"2387_CR54","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1177\/02841851251365512","volume":"66","author":"H Ersay","year":"1987","unstructured":"Ersay H, Hatipoglu HG, Guresci S (1987) ADC values compared to tumor grade and Ki-67 proliferation index detected by a digital image analysis program in meningiomas. Acta Radiol 66:1263\u20131270. https:\/\/doi.org\/10.1177\/02841851251365512","journal-title":"Acta Radiol"},{"key":"2387_CR55","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2478\/v10042-008-0098-0","volume":"47","author":"B Grala","year":"2009","unstructured":"Grala B, Markiewicz T, Koz\u0142owski W, Osowski S, S\u0142odkowska J, Papierz W (2009) New automated image analysis method for the assessment of Ki-67 labeling index in meningiomas. Folia Histochem Cytobiol 47:587\u2013592. https:\/\/doi.org\/10.2478\/v10042-008-0098-0","journal-title":"Folia Histochem Cytobiol"},{"key":"2387_CR56","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s11060-025-05057-2","volume":"174","author":"IY Shukla","year":"2025","unstructured":"Shukla IY, Ebada A, Bever N, Traylor JI, Wan B, Shah D et al (2025) Prognostic value of MIB-1 index in meningioma: a retrospective cohort study to establish an optimal cutoff for recurrence and survival. J Neurooncol 174:483\u2013492. https:\/\/doi.org\/10.1007\/s11060-025-05057-2","journal-title":"J Neurooncol"},{"key":"2387_CR57","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1440-1789.2007.00750.x","volume":"27","author":"J Bruna","year":"2007","unstructured":"Bruna J, Brell M, Ferrer I, Gimenez-Bonafe P, Tortosa A (2007) Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma. Neuropathol 27:114\u2013120. https:\/\/doi.org\/10.1111\/j.1440-1789.2007.00750.x","journal-title":"Neuropathol"},{"key":"2387_CR58","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1007\/s00701-019-04073-2","volume":"161","author":"F Wang","year":"2019","unstructured":"Wang F, Xu D, Liu Y, Lin Y, Wei Q, Gao Q et al (2019) Risk factors associated with postoperative recurrence in atypical intracranial meningioma: analysis of 263 cases at a single neurosurgical centre. Acta Neurochir (Wien) 161:2563\u20132570. https:\/\/doi.org\/10.1007\/s00701-019-04073-2","journal-title":"Acta Neurochir (Wien)"},{"key":"2387_CR59","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00401-017-1678-x","volume":"133","author":"A Olar","year":"2017","unstructured":"Olar A, Wani KM, Wilson CD, Zadeh G, DeMonte F, Jones DT et al (2017) Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma. Acta Neuropathol 133:431\u2013444. https:\/\/doi.org\/10.1007\/s00401-017-1678-x","journal-title":"Acta Neuropathol"},{"key":"2387_CR60","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s11060-022-04220-3","volume":"161","author":"J Singh","year":"2023","unstructured":"Singh J, Sharma R, Shukla N, Narwal P, Katiyar A, Mahajan S et al (2023) DNA methylation profiling of meningiomas highlights clinically distinct molecular subgroups. J Neurooncol 161:339\u2013356. https:\/\/doi.org\/10.1007\/s11060-022-04220-3","journal-title":"J Neurooncol"},{"key":"2387_CR61","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s40478-025-02184-9","volume":"13","author":"D Duckett","year":"2025","unstructured":"Duckett D, Santana-Santos L, McCord M, Smith V, Lopes MBS, Youngblood MW et al (2025) Development, validation, and utility of a clinically applicable methylation classifier for recurrence risk prediction in meningiomas. Acta Neuropathol Commun 13:259. https:\/\/doi.org\/10.1186\/s40478-025-02184-9","journal-title":"Acta Neuropathol Commun"},{"key":"2387_CR62","doi-asserted-by":"publisher","first-page":"6227","DOI":"10.3390\/cancers14246227","volume":"14","author":"S Hergalant","year":"2022","unstructured":"Hergalant S, Saurel C, Divoux M, Rech F, Pouget C, Godfraind C et al (2022) Correlation between DNA methylation and cell proliferation identifies new candidate predictive markers in meningioma. Cancers 14:6227. https:\/\/doi.org\/10.3390\/cancers14246227","journal-title":"Cancers"},{"key":"2387_CR63","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1136\/bmj.332.7549.1080","volume":"332","author":"DG Altman","year":"2006","unstructured":"Altman DG, Royston P (2006) The cost of dichotomising continuous variables. BMJ 332:1080. https:\/\/doi.org\/10.1136\/bmj.332.7549.1080","journal-title":"BMJ"},{"key":"2387_CR64","doi-asserted-by":"publisher","unstructured":"Hua S, Yan F, Shen T, Ma L, Zhang X (2024) PathoDuet: foundation models for pathological slide analysis of H&E and IHC stains [Internet]. arXiv; https:\/\/doi.org\/10.48550\/arXiv.2312.09894 [cited 8 Mar 2026]","DOI":"10.48550\/arXiv.2312.09894"},{"key":"2387_CR65","unstructured":"MahmoodLab. UNI2-h: pathology foundation model [Internet]. [cited 8 Mar 2026 ]. https:\/\/huggingface.co\/MahmoodLab\/UNI2-h. Accessed 8 Mar 2026"},{"key":"2387_CR66","doi-asserted-by":"publisher","first-page":"5190","DOI":"10.3390\/cancers15215190","volume":"15","author":"J Sehring","year":"2023","unstructured":"Sehring J, Dohmen H, Selignow C, Schmid K, Grau S, Stein M et al (2023) Leveraging attention-based convolutional neural networks for meningioma classification in computational histopathology. Cancers 15:5190. https:\/\/doi.org\/10.3390\/cancers15215190","journal-title":"Cancers"},{"key":"2387_CR67","doi-asserted-by":"publisher","unstructured":"Ayad MA, McCortney K, Congivaram HTS, Hjerthen MG, Steffens A, Zhang H, et al (2026) Morphological set enrichment enables interpretable prognostication and molecular profiling of meningiomas [Internet]. medRxiv; p. 2026.02.23.26346491. https:\/\/doi.org\/10.64898\/2026.02.23.26346491 [cited 12 Apr 2026]","DOI":"10.64898\/2026.02.23.26346491"},{"key":"2387_CR68","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1038\/s41591-024-02995-8","volume":"30","author":"D-T Hoang","year":"2024","unstructured":"Hoang D-T, Shulman ED, Turakulov R, Abdullaev Z, Singh O, Campagnolo EM et al (2024) Prediction of DNA methylation-based tumor types from histopathology in central nervous system tumors with deep learning. Nat Med 30:1952\u20131961. https:\/\/doi.org\/10.1038\/s41591-024-02995-8","journal-title":"Nat Med"},{"key":"2387_CR69","doi-asserted-by":"publisher","unstructured":"Hoang D-T, Shulman ED, Dhruba SR, Nair NU, Barman RK, Lalchungnunga H, et al (2025) Path2Omics: enhanced transcriptomic and methylation prediction accuracy from tumor histopathology. bioRxiv. ;2025.02.26.640189. https:\/\/doi.org\/10.1101\/2025.02.26.640189","DOI":"10.1101\/2025.02.26.640189"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-026-02387-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02387-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02387-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:03:09Z","timestamp":1785513789000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40478-026-02387-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2387"],"URL":"https:\/\/doi.org\/10.1186\/s40478-026-02387-8","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"17 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the institutional review board of the Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin (EA2\/059\/21). The requirement for individual informed consent was waived due to the retrospective nature of the study and the exclusive use of archival tissue specimens.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This manuscript does not contain any individual person\u2019s data in any form.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"157"}}